Amgen (AMGN)

Cost of Revenue

$2.81B

Quarterly · Period ending: · USD

AMGN logo

AMGN Cost of Revenue

Latest reported$2.81B
AMGN Quarterly Cost of Revenue ($0.00 → $2.81B)
High-resolution chart · PNG

AMGN cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
2,811,000,000
2,744,000,000
1,790,000,000
3,082,000,000
3,011,000,000
2,968,000,000
3,112,000,000
3,310,000,000
3,236,000,000
3,200,000,000
3,112,000,000
1,806,000,000
1,813,000,000
1,720,000,000
1,747,000,000
1,588,000,000
1,510,000,000
1,561,000,000
1,718,000,000
1,609,000,000
1,637,000,000
1,490,000,000
1,597,000,000
1,561,000,000
1,488,000,000
1,513,000,000
1,253,000,000
1,036,000,000
1,012,000,000
1,055,000,000
1,096,000,000
1,037,000,000
1,024,000,000
944,000,000
1,059,000,000
990,000,000
1,024,000,000
996,000,000
1,067,000,000
1,027,000,000
1,050,000,000
1,018,000,000
1,071,000,000
1,034,000,000
1,089,000,000
1,033,000,000
1,183,000,000
1,068,000,000
1,081,000,000
1,090,000,000
1,029,000,000
788,000,000
785,000,000
744,000,000
852,000,000
705,000,000
682,000,000
679,000,000
656,000,000
605,000,000
602,000,000
564,000,000
572,000,000
587,000,000
553,000,000
508,000,000
538,000,000
545,000,000
531,000,000
477,000,000
558,000,000
677,000,000
515,000,000
546,000,000
606,000,000
792,000,000
558,000,000
592,000,000
561,000,000
489,000,000
493,000,000
552,000,000
511,000,000
552,000,000
530,000,000
489,000,000
476,000,000
447,000,000
435,400,000
373,200,000
388,300,000
340,000,000
329,100,000
283,300,000
273,800,000
226,400,000
131,900,000
103,600,000
152,500,000
102,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.